The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds

Journal of Endotoxin Research

Volumn 9, Issue 6, 2003, Pages 381-384

  Heumann, Didier ^a   Lauener, Roger ^b   Ryffel, Bernard ^a  

^a CNRS   (France)

^b Division of Clinical Immunology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOPROTEIN; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL VIRULENCE; CELL KILLING; DEATH; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOST CELL; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INFLAMMATION; KLEBSIELLA PNEUMONIAE; MACROPHAGE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROVOCATION TEST; REVIEW; SALMONELLA TYPHIMURIUM; SEPTIC SHOCK; TREATMENT PLANNING;

ANIMALS; ANTIGENS, CD14; ENDOTOXINS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; SALMONELLA TYPHIMURIUM;

EID: 0347028369     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805103225003312     Document Type: Review

References (22)

1. Schumann RR, Leong SR, Flaggs GW et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429-1431.
2. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
3. Gallay P, Heumann D, Le Roy D, Barras C, Glauser MP. Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock. Proc Natl Acad Sci USA 1993; 90: 9935-9938.
4. Le Roy D, Di Padova F, Tees R et al. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14. J Immunol 1999; 162: 7454-7460.
5. Jack RS, Fan XL, Bernheiden M et al. Lipopolysaccharide-binding protein is required to combat a Gram-negative bacterial infection. Nature 1997; 389: 742-745.
6. Haziot A, Ferrero E, Köntgen F et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4: 407-414.
7. Schimke J, Mathison J, Morgiewicz J, Ulevitch RJ. Anti-CD14 mAb treatment provides therapeutic benefit after exposure to endotoxin. Proc Natl Acad Sci USA 1998; 95: 13875-13880.
8. Leturcq D, Moriarty AM, Talbott G, Winn RK, Martin TR, Ulevitch RJ. Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest 1996; 98: 1533-1538.
9. Aliprantis AO, Yang RB, Mark MR et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 1999; 285: 736-739.
10. Wooten RM, Morrison TB, Weis JH, Wright SD, Thieringer R, Weis JJ. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J Immunol 1998; 160: 5485-5492.
11. Giambartolomei GH, Dennis VA, Lasater BL, Philipp MT. Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immun 1999; 67: 140-147.
12. Soler-Rodriguez AM, Zhang H, Lichenstein H et al. Neutrophil activation by bacterial lipoprotein versus lipopolysaccharide: differential requirements for serum and CD14. J Immunol 2000; 164: 2674-2683.
13. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol 2000; 165: 618-622.
14. Werts C, Tapping RI, Mathison JC et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001; 2: 346-352.
15. Bainbridge BW, Darveau RP. Porphyromonas gingivalis lipopolysaccharide: an unusual pattern recognition receptor ligand for the innate host defense system. Acta Odontol Scand 2001; 59: 131-138.
16. Pridmore AC, Wyllie DH, Adbillahi F et al. A polysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via Toll-like receptor (TLR) 2 but not via TLR4/MD2. J Infect Dis 2001; 183: 89-96.
17. Le Roy D, Di Padova F, Adachi Y, Glauser MP, Calandra T, Heumann D. Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against Gram-negative bacteria. J Immunol 2001; 167: 2759-2765.
18. Cross A, Asher L, Seguin M et al. The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinal invasive Escherichia coli. J Clin Invest 1995; 96: 676-686.
19. Rosenstreich DL, Weinblatt AC, O'Brien AD. Genetic control of resistance to infection in mice. Crit Rev Immunol 1982; 3: 263-230.
20. Fierer J, Swancutt MA, Heumann D, Golenbock D. The role of lipopolysaccharide binding protein in resistance to Salmonella infections in mice. J Immunol 2002; 168, 6396-6403.
21. Wenneras C, Ave P, Huerre M et al. Blockade of CD14 increases Shigella-mediated invasion and tissue destruction. J Immunol 2000; 164: 3214-3221.
22. Gegner JA, Ulevitch RJ, Tobias PS. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 1995; 270: 5320-5325.